For example, the fact that miR-31-5p has been reported to be dysregulated in cystic pancreatic lesions has also been investigated in colorectal cancer patients, and it was demonstrated that the structural regulation of the miR-31-5p-dystrophin axis was altered in CRC patients. This evidence concerns the gene DMD and colorectal cancer.